Serodus ASA   Report issue

For profit Phase 2 Phase 3
Founded: Oslo Norway (2010)

Organization Overview

First Clinical Trial
2013
NCT01987284
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Serodus ASA